Predicting Mortality Risk in Viral and Unspecified Pneumonia to Assist
  Clinicians with COVID-19 ECMO Planning
  Respiratory complications due to coronavirus disease COVID-19 have claimed
tens of thousands of lives in 2020. Many cases of COVID-19 escalate from Severe
Acute Respiratory Syndrome (SARS-CoV-2) to viral pneumonia to acute respiratory
distress syndrome (ARDS) to death. Extracorporeal membranous oxygenation (ECMO)
is a life-sustaining oxygenation and ventilation therapy that may be used for
patients with severe ARDS when mechanical ventilation is insufficient to
sustain life. While early planning and surgical cannulation for ECMO can
increase survival, clinicians report the lack of a risk score hinders these
efforts. In this work, we leverage machine learning techniques to develop the
PEER score, used to highlight critically ill patients with viral or unspecified
pneumonia at high risk of mortality or decompensation in a subpopulation
eligible for ECMO. The PEER score is validated on two large, publicly available
critical care databases and predicts mortality at least as well as other
existing risk scores. Stratifying our cohorts into low-risk and high-risk
groups, we find that the high-risk group also has a higher proportion of
decompensation indicators such as vasopressor and ventilator use. Finally, the
PEER score is provided in the form of a nomogram for direct calculation of
patient risk, and can be used to highlight at-risk patients among critical care
patients eligible for ECMO.
